UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.218
EU - Europa 4.495
AS - Asia 2.308
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
AF - Africa 2
SA - Sud America 2
Totale 23.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.162
CN - Cina 1.404
UA - Ucraina 1.398
IT - Italia 1.129
DE - Germania 595
IE - Irlanda 545
VN - Vietnam 460
TR - Turchia 365
SE - Svezia 312
FI - Finlandia 260
RU - Federazione Russa 91
GB - Regno Unito 54
IN - India 53
CA - Canada 39
FR - Francia 36
CZ - Repubblica Ceca 23
EU - Europa 16
MX - Messico 12
JP - Giappone 9
PL - Polonia 8
AU - Australia 7
NZ - Nuova Zelanda 7
BE - Belgio 6
HK - Hong Kong 6
ES - Italia 5
GR - Grecia 5
CH - Svizzera 4
DK - Danimarca 4
LU - Lussemburgo 4
NL - Olanda 4
RO - Romania 4
CR - Costa Rica 3
IL - Israele 3
IR - Iran 3
KR - Corea 3
NO - Norvegia 2
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
PA - Panama 1
SG - Singapore 1
SV - El Salvador 1
Totale 23.055
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.156
Wilmington 2.249
Jacksonville 1.728
Princeton 1.634
Chandler 1.535
Houston 728
Woodbridge 616
Dublin 538
Dong Ket 459
Nanjing 398
Andover 368
Izmir 363
Ashburn 358
Boardman 288
Pellezzano 264
Beijing 262
Düsseldorf 216
Mestre 203
Norwalk 143
Shenyang 134
Fairfield 130
Hebei 121
Naples 116
Salerno 115
Changsha 109
Nanchang 108
Dearborn 107
Jiaxing 83
Redwood City 60
Tianjin 54
San Diego 48
Pune 44
West Jordan 35
Rome 32
Cambridge 30
Washington 28
Jinan 27
Ottawa 26
Milan 24
Seattle 23
Venezia 18
Brno 13
Lecce 11
Dormagen 10
Guangzhou 10
Lappeenranta 10
Napoli 10
Fuzhou 9
Hangzhou 9
Kunming 9
Falls Church 8
New York 8
Taizhou 8
Munich 7
Bologna 6
Frankfurt am Main 6
Lanzhou 6
Nocera Inferiore 6
Zhengzhou 6
Brussels 5
Grumo Appula 5
Hefei 5
Marigliano 5
Orange 5
Perugia 5
Saint Petersburg 5
Sant'arpino 5
Santa Maria A Vico 5
Tappahannock 5
Toronto 5
Wuhan 5
Casoria 4
Edinburgh 4
Indiana 4
London 4
Nerviano 4
Taiyuan 4
Torino 4
Torre del Greco 4
Canzo 3
Carpiano 3
Caserta 3
Cesena 3
Dallas 3
Des Moines 3
Detroit 3
Esslingen am Neckar 3
Frattamaggiore 3
Hanover 3
Heredia 3
Maywood 3
Menlo Park 3
Mercato San Severino 3
Montreal 3
Neuilly-sur-Seine 3
Norman 3
Oklahoma City 3
Pomigliano D'arco 3
Porto Recanati 3
Procida 3
Totale 18.285
Salva come PNG Salva come JPEG
Nome #
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 144
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 144
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 143
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 124
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 120
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 116
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 109
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 109
The natural history of multiple system atrophy: A prospective European cohort study 108
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 107
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial 107
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 103
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 103
Normative data for the Montreal Cognitive Assessment in an Italian population sample 102
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 101
Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study 99
Increased bilirubin levels in de novo Parkinson's disease 98
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 97
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 95
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 94
The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study 93
Affective theory of mind in patients with Parkinson's disease: comment 92
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 92
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 91
Malabsorption is uncommon in restless legs syndrome. 89
D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine. 88
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 87
The accuracy of the arginine growth hormone test in parkinsonism. 86
Aiming for study comparability in Parkinson's disease: Proposal for a modular set of biomarker assessments to be used in longitudinal studies 86
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 86
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 86
The alpha-synuclein gene in multiple system atrophy 85
Dopamine mediated responses in 6-OH-DA lesioned rats involve changes of the signal transduction. 83
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. 83
Diagnosis and management of Parkinson's disease dementia. Oct;62(10):1581-7. Review.PMID: 18822028 83
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Aug 15;23(11):1532-40.PMID: 18581467 83
Prophylaxis of migraine attacks with a calcium-channel blocker: flunarizine versus methysergide 83
Apathy and related executive syndromes in dementia associated with Parkinson's disease and in Alzheimer's disease 83
On the relationship between side of onset and cognition in Parkinson disease 83
Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression? 82
Pisa syndrome in Parkinson disease: An observational multicenter Italian study 82
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 82
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. 81
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 81
Gender and non motor fluctuations in Parkinson's disease: A prospective study 81
Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study 81
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 80
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 80
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study 80
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 80
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 79
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 79
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 78
Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors. 78
Pramipexole in patients with early Parkinson's disease (PROUD): A randomised delayed-start trial 78
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 78
Quitting smoking: An early non-motor feature of Parkinson's disease? 77
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 77
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 77
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 77
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 77
Apathy in Parkinson's disease: Diagnosis, neuropsychological correlates, pathophysiology and treatment 77
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 77
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. 76
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Oct;16(10):1090-9. Review.PMID: 19723294 76
Nitric oxide-haemoglobin interaction: a new biochemical hypothesis for signal changes in fMRI. 76
Plasma prolactin response to sodium valproate in epileptic patients 76
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease 76
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease 76
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 76
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 75
Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. 75
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 75
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 75
Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade. 74
D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models andparkinsonian patients. 74
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 74
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 74
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 74
Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine. 73
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 73
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 73
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 73
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease-Report of the JPND Working Group BioLoC-PD 73
Inhibition of septal hyperreactivity by testosterone and its reversion by an estrogen antagonist in weanling female rats 73
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 73
The relevance of gender in Parkinson's disease: a review 72
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 72
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 72
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 72
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 72
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 71
Wine drinking and essential tremor: a possible protective role. 71
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease. 71
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 71
The role of embodied simulation in mental transformation of whole-body images: Evidence from Parkinson's disease 71
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 71
The status of dopamine nerve terminals in Parkinson\'s disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. 70
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 70
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 70
Totale 8.473
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019781 0 0 0 0 0 0 0 0 0 156 565 60
2019/20203.228 991 98 367 27 239 53 313 29 280 238 547 46
2020/20212.645 24 248 270 10 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20241.397 159 310 110 163 100 197 86 131 71 70 0 0
Totale 24.068